Data di Pubblicazione:
2021
Abstract:
Idiopathic pulmonary fibrosis (IPF) is the most common among idiopathic interstitial pneumonia. Life expectancy is estimated around 3-5 years at diagnosis. No reliable prognostic biomarker has been approved for routinary clinical practice of IPF. The aim of this study is to investigate the potential prognostic value of serum CD59 in a cohort of IPF patients.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adult; Aged; Aged; 80 and over; Biomarkers; Case-Control Studies; CD59 Antigens; Female; Humans; Idiopathic Pulmonary Fibrosis; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Retrospective Studies; Survival
Elenco autori:
Cameli, Paolo; Bergantini, Laura; D'Alessandro, Miriana; Vietri, Lucia; Cameli, Matteo; Sestini, Piersante; Bargagli, Elena
Link alla scheda completa:
Pubblicato in: